Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tubulin targeting agents

W N Hait¹, E Rubin, S Goodin

¹Department of Medicine, UMDNJ/Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ, USA.

Cancer Chemotherapy and Biological Response Modifiers

|November 1, 2001

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine-learning-based risk assessment tool to rule out empirical use of ESBL-targeted therapy in endemic areas.

The Journal of hospital infection·2024

Same author

Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

Comment.

Statistics in biopharmaceutical research·2018

Same author

Systemic chromosome instability in Shugoshin-1 mice resulted in compromised glutathione pathway, activation of Wnt signaling and defects in immune system in the lung.

Oncogenesis·2016

Same author

Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same author

A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Blood cancer journal·2014